Correlation Between Edgewise Therapeutics and Rallybio Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Rallybio Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Rallybio Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Rallybio Corp, you can compare the effects of market volatilities on Edgewise Therapeutics and Rallybio Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Rallybio Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Rallybio Corp.

Diversification Opportunities for Edgewise Therapeutics and Rallybio Corp

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Edgewise and Rallybio is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Rallybio Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rallybio Corp and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Rallybio Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rallybio Corp has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Rallybio Corp go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and Rallybio Corp

Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Rallybio Corp. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 1.18 times less risky than Rallybio Corp. The stock trades about -0.14 of its potential returns per unit of risk. The Rallybio Corp is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  103.00  in Rallybio Corp on August 24, 2024 and sell it today you would lose (4.00) from holding Rallybio Corp or give up 3.88% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Edgewise Therapeutics  vs.  Rallybio Corp

 Performance 
       Timeline  
Edgewise Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Edgewise Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Rallybio Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rallybio Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Edgewise Therapeutics and Rallybio Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edgewise Therapeutics and Rallybio Corp

The main advantage of trading using opposite Edgewise Therapeutics and Rallybio Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Rallybio Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rallybio Corp will offset losses from the drop in Rallybio Corp's long position.
The idea behind Edgewise Therapeutics and Rallybio Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Money Managers
Screen money managers from public funds and ETFs managed around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.